Feb. 3 at 12:56 AM
$PSTV Scenarios for CNSide Revenue
These are scenarios only and have not been stated by PSTV, but the odds are numbers like these will be addressed sometime in the near future.
1) Conservative (Low Adoption)
Suppose only a small fraction of potential tests are performed in 2026 (e.g., tens of thousands of tests).
At an assumed price of
$1,000–
$2,000/test, revenue might be
$10 M–
$30 M+ in the first full commercial year.
2) Moderate (Steady Growth)
If CNSide captures a meaningful slice of its market (for example, early adopters in specialty centers and broader insurer coverage):
Revenue could rise to
$50 M–
$100 M+ in 2026/2027 with increasing test volumes.
3) Aggressive (Broad Adoption)
If CNSide reaches larger penetration into the ~
$6 billion total market over the next several years, annual revenue could be in the hundreds of millions — though this would depend on reimbursement rates, utilization per patient, and competitive dynamics.
